BIRMINGHAM, Ala. & CLEMMONS, N.C.–(BUSINESS WIRE)–Advancing Sight Network and Miracles In Sight today jointly announced the merger of the two organizations, which will begin operating as one on January 1, 2026. Globally, at least 253 million people l…
Category: News
DefEYE, Inc. Announces Investment from ExSight Ventures
NEW YORK–(BUSINESS WIRE)–ExSight Ventures, a leading venture capital firm focused on transformational eye care innovations, today announced its investment in DefEYE, Inc., a rapidly growing ocular company developing decellularized placental-based tis…
PRISM Vision Group Marks Milestone in National Expansion with Spokane Eye Clinic Affiliation
NEW PROVIDENCE, N.J.–(BUSINESS WIRE)–PRISM Vision Group closed a transaction with Spokane Eye Clinic, through which Spokane Eye Clinic joins PRISM’s network of affiliated practices.
Seborrheic Dermatitis Linked to Epithelial Barrier Diseases
Adults with seborrheic dermatitis appear more likely to have other epithelial barrier diseases, including atopic dermatitis, psoriasis, rosacea, irritable bowel syndrome, and dry eye, suggesting shared inflammatory pathways. Medscape Medical News
PolyActiva and RareSight Form Strategic Collaboration to Develop Breakthrough Treatments for Rare Pediatric Retinal Diseases
FORT WORTH, Texas & MELBOURNE, Australia & MENLO PARK, Calif.–(BUSINESS WIRE)–PolyActiva, a clinical-stage biopharmaceutical company pioneering a novel drug delivery technology to improve outcomes for patients with ocular conditions, and RareSight, I…
Eyexora Establishes Co-Headquarters in Singapore to Accelerate Growth Across Asia-Pacific
SINGAPORE–(BUSINESS WIRE)–Eyexora Establishes Co-Headquarters in Singapore to Accelerate Growth Across Asia-Pacific
Tenpoint Therapeutics Ltd. Announces Submission of a New Drug Application for BRIMOCHOL™ PF for the Treatment of Presbyopia to the MFDS in South Korea
LONDON & SEATTLE & HONG KONG–(BUSINESS WIRE)–Tenpoint Therapeutics, Ltd., a global, commercial-ready biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announced that its partner, Zhaoke…
LambdaVision Raises $7M Seed Round to Revolutionize Blindness Treatment Using Space-Based Manufacturing
WOODBRIDGE, Conn.–(BUSINESS WIRE)–LambdaVision, a biotech innovator leveraging microgravity to manufacture its investigational protein-based artificial retina to help patients regain sight lost to retinal degenerative diseases, has closed a $7M seed …
Viridian Therapeutics Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today reported recent busine…
National Vision Holdings, Inc. Reports Third Quarter 2025 Financial Results
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision,” “we,” “our,” “us” or the “Company”) today reported its financial results for the third quarter ended September 27, 2025. “Our strong performance this quarter…
Diabetic Retinopathy May Worsen After YAG Laser Treatment
Yttrium aluminum garnet laser capsulotomy after cataract surgery is tied to an increased risk for the progression of nonproliferative diabetic retinopathy and development of other serious eye issues. Medscape Medical News
AAO 2025: Evolving Approaches in Retinal Disorders
Dr Sunir Garg shares insights on patient management, medication impact, and advancing technologies that are shaping the future of eye health. Medscape
Broadwood Partners Condemns Alcon’s Fallacious Attacks on STAAR Surgical and Its Prospects
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today commented on the investor presentation issued by Alcon Inc. (“Alcon”) (NYSE: ALC) regarding its proposed acquisition of STAAR Surgical Company (“STAAR” o…
Sydnexis Announces Topline Pivotal Data from Phase 3 STAR Trial of SYD-101 for Patients with Pediatric Progressive Myopia Presented at AMCP Nexus 2025
DEL MAR, Calif.–(BUSINESS WIRE)–Sydnexis Announces Topline Pivotal Data from Phase 3 STAR Trial of SYD-101 for Patients with Pediatric Progressive Myopia Presented at AMCP Nexus 2025
Ocular Rosacea Underappreciated in Dermatology and Beyond
For ocular rosacea, dermatologists can do more than hand off patients to ophthalmology by asking the right questions and applying treatments they are already using. Medscape Medical News
Systemic Therapy for Sjögren Closer With Phase 3 Success
Current treatment options have been limited to symptom control. Telitacicept, a novel fusion protein, and ianalumab, a monoclonal antibody, demonstrate improvement in disease activity. Medscape Medical News
Viridian Therapeutics Announces Successful October Submission of Biologics License Application (BLA) to U.S. FDA for Veligrotug in Thyroid Eye Disease
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today announced the successf…
Glaukos Announces Participation in Upcoming Investor Conferences
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that i…
Chemotherapy Drug Shortages Become Cancer-Care Reality
Shortages to backbone chemotherapy drugs are negatively affecting patient care, and more shortages are likely without policy solutions, experts say. Medscape Medical News
HTC and IngenioSpec Settled ITC Dispute on Electronic Eyewear Products
WACO, Texas–(BUSINESS WIRE)– #audio–IngenioSpec Resolves Patent Dispute with HTC on Electronic Eyewear Technology.